Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medical device reporting: another final rule, Part I.

M Donawa1

  • 1Donawa and Associates Ltd, Rome, Italy. donawa@srd.it

Medical Device Technology
|August 1, 2000
PubMed
Summary

Navigating the US Medical Device Reporting (MDR) Regulation presents compliance challenges. A new MDR regulation offers clarifications but leaves some issues unresolved, particularly for international companies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Center for Devices and Radiological health: an update.

Medical device technology·2005
Same author

Notified Body guidance on clinical evaluation.

Medical device technology·2004
Same author

Drug delivery systems: avoiding the pitfalls.

Medical device technology·2004
Same author

New FDA guidance on electronic records and signatures.

Medical device technology·2003
Same author

Update on the European database.

Medical device technology·2003
Same author

An important step forward in the global harmonisation of premarket review programmes.

Medical device technology·2003

Area of Science:

  • Regulatory Affairs
  • Medical Device Compliance
  • Health Policy

Background:

  • The United States Medical Device Reporting (MDR) Regulation has a complex history.
  • Compliance with existing MDR requirements poses significant challenges for manufacturers.

Purpose of the Study:

  • To provide a historical overview of the US MDR Regulation.
  • To analyze specific MDR requirements relevant to non-US companies.
  • To discuss the implications of the newly published MDR regulation.

Main Methods:

  • Chronological review of historical MDR regulations.
  • Analysis of key reporting requirements.
  • Discussion of the new MDR regulation's content.

Main Results:

  • The history of the US MDR Regulation is intricate, complicating compliance efforts.
  • The new MDR regulation addresses some, but not all, prior reporting ambiguities.
  • Part I details historical regulations and requirements for international firms.

Conclusions:

  • Understanding the historical context of the US MDR Regulation is crucial for effective compliance.
  • The updated MDR regulation provides partial clarity, necessitating continued attention to reporting obligations.
  • Non-US companies must carefully review specific requirements outlined in the new regulation.

Related Experiment Videos